These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 20584506)

  • 41. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
    Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Chemoradiation therapy using radiotherapy, systemic chemotherapy with 5-fluorouracil and nedaplatin, and intra-arterial infusion using carboplatin for locally advanced head and neck cancer - Phase II study.
    Fuwa N; Kodaira T; Furutani K; Tachibana H; Nakamura T; Daimon T
    Oral Oncol; 2007 Nov; 43(10):1014-20. PubMed ID: 17258494
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Concomitant cisplatin, paclitaxel, and hyperfractionated radiotherapy in locally advanced head and neck cancer: comparison of two different schedules.
    Moreno-Jiménez M; Valero J; López-Picazo JM; Arbea L; Aristu J; Cambeiro M; Alcalde J; Martínez-Monge R
    Am J Clin Oncol; 2010 Apr; 33(2):137-43. PubMed ID: 19786847
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neck.
    Budach W; Hehr T; Budach V; Belka C; Dietz K
    BMC Cancer; 2006 Jan; 6():28. PubMed ID: 16448551
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Curative-Intent Aggressive Treatment Improves Survival in Elderly Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma and High Comorbidity Index.
    Chen JH; Yen YC; Yang HC; Liu SH; Yuan SP; Wu LL; Lee FP; Lin KC; Lai MT; Wu CC; Chen TM; Chang CL; Chow JM; Ding YF; Wu SY
    Medicine (Baltimore); 2016 Apr; 95(14):e3268. PubMed ID: 27057882
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comorbidity and performance status as independent prognostic factors in patients with head and neck squamous cell carcinoma.
    Wang JR; Habbous S; Espin-Garcia O; Chen D; Huang SH; Simpson C; Xu W; Liu FF; Brown DH; Gilbert RW; Gullane PJ; Irish JC; Goldstein DP; Liu G
    Head Neck; 2016 May; 38(5):736-42. PubMed ID: 25521753
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The impact of comorbidity on outcome in 12 623 Danish head and neck cancer patients: a population based study from the DAHANCA database.
    Bøje CR; Dalton SO; Grønborg TK; Primdahl H; Kristensen CA; Andersen E; Johansen J; Andersen LJ; Overgaard J
    Acta Oncol; 2013 Feb; 52(2):285-93. PubMed ID: 23320773
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pre-therapeutic fibrinogen levels are of prognostic significance in locally advanced head and neck cancer.
    Selzer E; Grah A; Heiduschka G; Kornek G; Thurnher D
    Wien Klin Wochenschr; 2016 May; 128(9-10):320-8. PubMed ID: 26919854
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Predictive factors of survival and treatment tolerance in older patients treated with chemotherapy and radiotherapy for locally advanced head and neck cancer.
    Bahig H; Fortin B; Alizadeh M; Lambert L; Filion E; Guertin L; Ayad T; Christopoulos A; Bissada E; Soulières D; Gaba Idiamey F; Nguyen-Tan PF
    Oral Oncol; 2015 May; 51(5):521-8. PubMed ID: 25797461
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Elderly patients affected by head and neck squamous cell carcinoma unfit for standard curative treatment: Is de-intensified, hypofractionated radiotherapy a feasible strategy?
    Bonomo P; Desideri I; Loi M; Lo Russo M; Olmetto E; Maragna V; Francolini G; Delli Paoli C; Grassi R; Pezzulla D; Greto D; Meattini I; Livi L
    Oral Oncol; 2017 Nov; 74():142-147. PubMed ID: 29103743
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Validity of the age-adjusted charlson comorbidity index on clinical outcomes for patients with nasopharyngeal cancer post radiation treatment: a 5-year nationwide cohort study.
    Yang CC; Chen PC; Hsu CW; Chang SL; Lee CC
    PLoS One; 2015; 10(1):e0117323. PubMed ID: 25617629
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect on long-term survival of psychiatric disorder, inflammation, malnutrition, and radiotherapy-related toxicity in patients with locally advanced head and neck cancer.
    Unal D; Eroglu C; Ozsoy SD; Besirli A; Orhan O; Kaplan B
    J BUON; 2015; 20(3):886-93. PubMed ID: 26214644
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Age-adjusted Charlson Comorbidity Index predicts prognosis of laryngopharyngeal cancer treated with radiation therapy.
    Takemura K; Takenaka Y; Ashida N; Shimizu K; Oya R; Kitamura T; Yamamoto Y; Uno A
    Acta Otolaryngol; 2017 Dec; 137(12):1307-1312. PubMed ID: 28875745
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comorbidity in head and neck cancer: a critical appraisal and recommendations for practice.
    Paleri V; Wight RG; Silver CE; Haigentz M; Takes RP; Bradley PJ; Rinaldo A; Sanabria A; Bień S; Ferlito A
    Oral Oncol; 2010 Oct; 46(10):712-9. PubMed ID: 20850371
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Validation of a one-page patient-reported Charlson comorbidity index questionnaire for upper aerodigestive tract cancer patients.
    Habbous S; Chu KP; Harland LT; La Delfa A; Fadhel E; Sun B; Xu W; Wong A; Howell D; Ringash J; Waldron J; O'Sullivan B; Goldstein D; Huang SH; Liu G
    Oral Oncol; 2013 May; 49(5):407-12. PubMed ID: 23291295
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impact of comorbidity on initial treatment and overall survival in elderly head and neck cancer patients.
    Chokshi S; Ghobadi A; Athar M; Shah S; Dowell J
    Anticancer Res; 2014 Oct; 34(10):5543-6. PubMed ID: 25275053
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comorbidity as predictor poor prognosis for patients with advanced head and neck cancer treated with major surgery.
    Omura G; Ando M; Saito Y; Kobayashi K; Yamasoba T; Asakage T
    Head Neck; 2016 Mar; 38(3):364-9. PubMed ID: 25331962
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impact of severe malnutrition on short-term mortality and overall survival in head and neck cancer.
    Datema FR; Ferrier MB; Baatenburg de Jong RJ
    Oral Oncol; 2011 Sep; 47(9):910-4. PubMed ID: 21802345
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Age-adjusted comorbidity and survival in locally advanced laryngeal cancer.
    ; Mulcahy CF; Mohamed ASR; Kanwar A; Hutcheson KA; Ghosh A; Vock D; Weber RS; Lai SY; Gunn GB; Zafereo M; Morrison WH; Ferrarotto R; Garden AS; Rosenthal DI; Fuller CD
    Head Neck; 2018 Sep; 40(9):2060-2069. PubMed ID: 29756307
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Choosing a concomitant chemotherapy and radiotherapy regimen for squamous cell head and neck cancer: A systematic review of the published literature with subgroup analysis.
    Browman GP; Hodson DI; Mackenzie RJ; Bestic N; Zuraw L;
    Head Neck; 2001 Jul; 23(7):579-89. PubMed ID: 11400247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.